Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?

Area of Science:

• Oncology
• Surgical Pathology
• Radiation Oncology

Background:

• Sentinel node biopsy (SNB) has replaced axillary dissection for early-stage breast cancer, reducing patient morbidity.
• Positive SNB results create controversy regarding optimal axillary staging and treatment.
• Radiation therapy is a historical and current consideration for nodal management.

Purpose of the Study:

• To review the management of patients with positive sentinel node biopsy.
• To examine outcomes for patients with positive SNB who do not undergo completion dissection.
• To discuss toxicities associated with axillary irradiation in this context.

Main Methods:

• Literature review of studies on sentinel node biopsy in breast cancer.
• Analysis of data on outcomes following positive SNB without completion dissection.
• Evaluation of toxicities related to axillary radiation therapy.

Main Results:

• Limited data exists on the outcomes of patients with positive SNB who avoid completion dissection.
• Axillary irradiation is an established modality with known toxicities.
• The review synthesizes existing experience to inform management decisions.

Conclusions:

• Management of positive SNB requires careful consideration of available data and treatment options.
• A proposed approach for managing patients with positive SNB is presented.
• Balancing oncologic control with treatment morbidity is crucial.